Yiling Company Profile
✉ Email this page to a colleague
What is the competitive landscape for YILING
YILING has fifteen approved drugs.
Drugs and US Patents for Yiling
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Yiling | ACYCLOVIR | acyclovir | TABLET;ORAL | 210401-002 | Mar 7, 2018 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Yiling | ACYCLOVIR | acyclovir | TABLET;ORAL | 210401-001 | Mar 7, 2018 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Yiling | CELECOXIB | celecoxib | CAPSULE;ORAL | 211412-001 | Mar 6, 2020 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

